Ticagrelor
Top View
- Role of P2Y Receptors in Platelet Extracellular Vesicle Release
- Adenosine Receptor Agonist HE-NECA Enhances Antithrombotic Activities of Cangrelor and Prasugrel in Vivo by Decreasing of Fibrinogen Density in Thrombus
- Review Article
- Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
- Effect of GPVI-Fc in Combination with Standard Antiplatelet Drugs and of GPVI-Fc Fused to CD39 on Platelet Thrombus Formation
- DUAL ANTIPLATELET THERAPY: Who, What, When, How Long?
- Microglia and Neuroinflammation: What Place for P2RY12?
- Treatment with Apixaban | Eliquis |
- Effect of Chewing Vs Swallowing Ticagrelor On
- Therapeutic Class Overview Platelet Inhibitors
- P2Y12 Inhibition in Macrophages Reduces Ventricular Arrhythmias in Rats After Myocardial Ischemia-Reperfusion
- (Therapeutic Products) Regulations 2015
- FEP 5 Tier Rx Drug Formulary (607) Standard Option
- Platelet Purinergic Receptors in Thrombosis and Inflammation Gachet, Hechler
- Tenncare Attestation List September 1, 2021
- Downloads/Drugs/.../Guidances/UCM072137.Pdf [Cited 2014 Nov 3]
- Luna Investments
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort